Scientific publication reports clinical evidence for PainDrainer’s unique pain app
LUND, SWEDEN – A published clinical study from the University of California San Diego Health Science in collaboration with PainDrainer AB shows a significant increase in quality of life and a significant decrease in pain levels in chronic pain patients already after about 6 weeks of using PainDrainer’s digital tool.
PainDrainer® is the first digital pain coach powered by artificial intelligence (AI), which makes it completely patient-centric. This is crucial for effective pain management because each individual’s situation is different.
”It is very gratifying that PainDrainer’s first clinical study now has been reviewed and published. Achieving clinical evidence is an important milestone for the company’s promising development so it is positive and very welcome that the study is published.”, says Erik Frick, CEO PainDrainer AB.
PainDrainer AB is a Swedish company based at Medicon Village in Lund, and is developed in collaboration with leading hospitals and pain specialists in Scandinavia and the USA.
The company has ongoing clinical studies with Weill Cornell Medicine, New York, Newton-Wellesley Hospital, Boston and Skåne University Hospital, Lund. The purpose is to further document how effectively PainDrainer® contributes to increased quality of life and reduce patients’ pain.
The scientific publication can be read at https://www.anncaserep.com/open-access/a-drug-free-digital-self-management-tool-for-chronic-pain-patients-powered-8982.pdf
PainDrainer® is available at App Store and Googel Play.
For more information, please contact:
Erik Frick VD PainDrainer AB erik.frick@paindrainer.com +46 736 612123
About PainDrainer AB PainDrainer AB is a company developing digital platforms and applications contributing to health and well-being. PainDrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement (chronic pain patient herself), and Göran Barkfors (IT specialist). The idea was born when Maria, after participating in several pain rehabilitation programs, realized that the pain is affected by more factors than the human brain can keep track of, since all days are different. PainDrainer® which is completely patient-centric uses advanced calculations based on artificial intelligence to, based on each user’s own data, coach the user in planning their day not to exceed a certain pain level, and to ensure that there is energy left for activities highly valued.
PainDrainer® has clinical evidence, is based on Acceptance and Commitment Therapy (ACT), self-management and artificial intelligence (AI). It is CE certified and is cleared by FDA as a Mobile Medical Device class 1 with exemption. www.paindrainer.com